首页|miR-339-5p调控EMT影响乳腺癌细胞化疗耐药的机制

miR-339-5p调控EMT影响乳腺癌细胞化疗耐药的机制

扫码查看
目的 分析miR-339-5p调控上皮细胞-间充质转化(EMT)影响乳腺癌细胞化疗耐药的机制。方法 于2023年2月至2024年2月体外培养正常乳腺上皮细胞系(MCF10A)及乳腺癌细胞系MCF-7,构建乳腺癌紫杉醇耐药细胞系MCF-7/紫杉醇,将MCF-7/紫杉醇细胞分别转染miR-339-5p模拟物(miR-339-5p mimics 组)、miR-339-5p 模拟物阴性对照(miR-NC 组)、miR-339-5p 抑制剂(miR-339-5p inhibitor组)及miR-339-5p抑制剂对照(NC组)。采用实时荧光定量逆转录聚合酶链反应(qRT-PCR)对miR-339-5p水平予以检测,以噻唑蓝(MTT)法测定细胞增殖抑制率,经流式细胞仪测定细胞凋亡情况,采用Western Blot法检测EMT相关蛋白[E-cadhesin(E-cad)、Vimentin(Vim)]的表达。采用独立样本t检验、ONE-WAY ANOVA分析及LSD-t检验对所获得的数据进行统计学分析。结果 miR-339-5p 在 MCF-7 细胞的表达水平低于 MCF10A 细胞[(0。36±0。07)比(0。73±0。08),P<0。05];转染48 h后,miR-339-5p mimics组细胞增殖抑制率、细胞凋亡率高于miR-NC组[(45。86±4。92)%比(20。44±2。16)%、(16。54±1。67)%比(4。23±0。45)%,均P<0。05],miR-339-5p inhibitor组细胞增殖抑制率、细胞凋亡率低于 NC 组[(9。74±1。05)%比(17。18±1。84)%、(2。28±0。46)%比(5。43±0。59)%,均P<0。05];miR-339-5p mimics 组 E-cad 水平高于 miR-NC 组,Vim 低于 miR-NC 组[(0。78±0。07)比(0。42±0。05)、(0。42±0。05)比(0。61±0。07),均 P<0。05],miR-339-5p inhibitor组 E-cad 低于 NC 组,Vim 高于 NC 组[(0。23±0。04)比(0。34±0。05)、(0。84±0。09)比(0。69±0。08),均 P<0。05]。结论 miR-339-5p 可降低乳腺癌细胞化疗耐药性,抑制细胞增殖并促进细胞凋亡,其机制可能是通过调控EMT相关蛋白E-cad、Vim而抑制 EMT。
Mechanism of miR-339-5p influencing chemotherapy resistance of breast cancer cells via regulating EMT
Objective To analyze the mechanism of miR-339-5p influencing chemotherapy resistance of breast cancer cells via regulating epithelial mesenchymal transformation(EMT).Methods From February 2023 to February 2024,MCF10A mammary epithelial cells and MCF-7 breast cancer cell lines were cultured in vitro.The paclitaxel resistant breast cancer cell line(MCF-7/paclitaxel)was constructed.The MCF-7/paclitaxel cells were divided into a miR-339-5p mimics group,a miR-339-5p mimetic negative control group(miR-NC group),a miR-339-5p inhibitor group,and a miR-339-5p inhibitor control group(NC group).The real-time fluorescence quantitative reverse transcription polymerase chain reaction(qRT-PCR)was used to detect the expression level of miR-339-5p.The methyl thiazolyl tetrazolium(MTT)assay was used to determine the inhibition rate of cell proliferation.The flow cytometry was used to determine cell apoptosis.The expression of EMT related proteins[E-cadherin(E-cad)and Vimentin(Vim)]was detected using the Western blot method.The independent sample t test,one-way ANOVA,and LSD-t test were used for the statistical analysis of the obtained data.Results The expression level of miR-339-5p in the MCF-7 cells was lower than that in the MCF10A cells[(0.36±0.07)vs.(0.73±0.08);P<0.05].Forty-eight h after transfection,the proliferation inhibition rate and apoptosis rate in the miR-339-5p mimics group were higher than those in the miR-NC group[(45.86±4.92)%vs.(20.44±2.16)%and(16.54±1.67)%vs.(4.23±0.45)%;both P<0.05].The cell proliferation inhibition rate and apoptosis rate of the miR-339-5p inhibitor group were lower than those of the NC group[(9.74±1.05)%vs.(17.18±1.84)%and(2.28±0.46)%vs.(5.43±0.59)%,both P<0.05].The E-cad level in the miR-339-5p mimics group was higher than that in the miR-NC group[(0.78±0.07)vs.(0.42±0.05);P<0.05];the Vim level in the miR-339-5p mimics group was lower than that in the miR-NC group[(0.42±0.05)vs.(0.61±0.07);P<0.05].The E-cad level in the miR-339-5p inhibitor group was lower than that in the NC group[(0.23±0.04)vs.(0.34±0.05);P<0.05];the Vim level in the miR-339-5p inhibitor group was higher than that in the NC group[(0.84±0.09)vs.(0.69±0.08);P<0.05].Conclusions MiR-339-5p can reduce chemotherapy resistance of breast cancer cells,inhibit cell proliferation,and promote cell apoptosis.The mechanism may be that it inhibits EMT regulating EMT related proteins——E-cad and Vim.

Breast cancerMiR-339-5pEpithelial mesenchymal transformationChemotherapy resistanceMechanism

李志路、乔喜婷、焦婉、王小娟、司小敏

展开 >

咸阳市中心医院肿瘤中心一病区及安宁病区,咸阳 712000

乳腺癌 miR-339-5p 上皮细胞-间充质转化 化疗耐药 机制

吴阶平医学基金会临床科研专项资助基金

320.6750.2022-18-45

2024

国际医药卫生导报
中华医学会,国际医药卫生导报社

国际医药卫生导报

影响因子:0.781
ISSN:1007-1245
年,卷(期):2024.30(19)